Emergency competitive revisions for research on repurposing existing therapeutics to address COVID-19.

NCATS is particularly interested in projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun.

Eligibility (if available)

Existing NCATS grantholders

Country
Date of announcement
Date application deadline